SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Teresa Botta-Orfila, Xavier Morató, Yaroslau Compta, Juan José Lozano, Neus Falgàs, Francesc Valldeoriola, Claustre Pont-Sunyer, Dolores Vilas, Lourdes Mengual, Manel Fernández, José Luis Molinuevo, Anna Antonell, Maria José Martí, Rubén Fernández-Santiago, Mario Ezquerra, Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease, Journal of Neuroscience Research, 2014, 92, 8
  2. 2
    Sang-Myung Cheon, Lilian Chan, Daniel Kam Yin Chan, Jae Woo Kim, Genetics of Parkinson’s Disease - A Clinical Perspective, Journal of Movement Disorders, 2012, 5, 2, 33

    CrossRef

  3. 3
    Sara J. Johnson, Richard Wade-Martins, A BACwards glance at neurodegeneration: molecular insights into disease fromLRRK2,SNCAandMAPTBAC-transgenic mice, Biochemical Society Transactions, 2011, 39, 4, 862

    CrossRef

  4. 4
    Fernando Calahorro, Manuel Ruiz-Rubio, Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson’s disease, Alzheimer’s disease and autism spectrum disorder, Invertebrate Neuroscience, 2011, 11, 2, 73

    CrossRef

  5. 5
    Z. Liu, S. Hamamichi, B. Dae Lee, D. Yang, A. Ray, G. A. Caldwell, K. A. Caldwell, T. M. Dawson, W. W. Smith, V. L. Dawson, Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models, Human Molecular Genetics, 2011, 20, 20, 3933

    CrossRef

  6. 6
    John N. Caviness, LihFen Lue, Charles H. Adler, Douglas G. Walker, Parkinson's Disease Dementia and Potential Therapeutic Strategies, CNS Neuroscience & Therapeutics, 2011, 17, 1
  7. 7
    Stanley Fahn, Joseph Jankovic, Mark Hallett, Principles and Practice of Movement Disorders, 2011,

    CrossRef

  8. 8
    Mohammad Reza Noori-Daloii, Majid Kheirollahi, Parinaz Mahbod, Fatemeh Mohammadi, Ali Nazeri Astaneh, Mohammad Reza Zarindast, Cyrus Azimi, Mohammad Reza Mohammadi, Alpha- and Beta-Synucleins mRNA Expression in Lymphocytes of Schizophrenia Patients, Genetic Testing and Molecular Biomarkers, 2010, 14, 5, 725

    CrossRef

  9. 9
    John Hardy, Genetic Analysis of Pathways to Parkinson Disease, Neuron, 2010, 68, 2, 201

    CrossRef

  10. 10
    Rachel Saunders-Pullman, Matthew J. Barrett, Kaili M. Stanley, Marta San Luciano, Vicki Shanker, Lawrence Severt, Ann Hunt, Deborah Raymond, Laurie J. Ozelius, Susan B. Bressman, LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson disease, Movement Disorders, 2010, 25, 15
  11. 11
    Yunjong Lee, Tet-Off Conditional Transgenic Approaches in Modeling Parkinson&#39s Disease in Mice, Interdisciplinary Bio Central, 2010, 2, 2, 1

    CrossRef